Navigation Links
Researchers make promising discovery in pursuit of effective lymphoma treatments
Date:5/16/2012

ctive pathway, the lymphoma cells are able to evade apoptosis, or cell death, allowing them to proliferate in an uncontrolled way.

"Activating mutations in the NF-кB pathway does not generally represent the initial oncogenic event," Dr. Pagano said. "But they are necessary for the survival and spread of the cancer."

Dr. Pagano explained the steps involved with pathway's activation and deactivation in more scientific detail: The process begins in the pathway's off state, with the accumulation of p100. To clear the pathway and naturally turn it back on, a sequence of events has to happen. First, a kinase, which the team identified as GSK3, phosphorylates p100. The phosphorylation draws the attention of Fbxw7α, a subunit of a ubiquitin ligase, which binds to the portion of p100 that has been phosphorylated by GSK3. The addition of Fbxw7α to the p100 protein then causes ubiquitin to seek out p100. Ubiquitin attaches to the protein and modifies it in a way such that it is recognized by a protease whose job it is to recognize and degrade any protein that has been modified by ubiquitin conjugation. As a result, p100 is degraded in the nucleus of the cell and the pathway is cleared and activated, turning on the gene transcription signal.

These new findings lead the researchers to conclude that the intersection of GSK3, Fbxw7α and p100 may serve as a potential intervention point for the treatment of multiple myeloma. Researchers believe if they can find a way to target the elimination of p100 they may be able to inactivate the pathway, which would eliminate the tumor cells' safe haven so that they would be susceptible to apoptosis. This would in turn promote the death of multiple myeloma cells.

According to Dr. Pagano, this strategy may not be too far from becoming a reality. There are already drugs being tested in clinical trials for Alzheimer's Disease that work by inhibiting GSK3. With the current study, the resea
'/>"/>

Contact: Jessica Guenzel
jessica.guenzel@nyumc.org
212-404-3591
NYU Langone Medical Center / New York University School of Medicine
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Breast cancer effectively treated with chemical found in celery, parsley by MU researchers
2. New biomarker test predicts arthritis at much earlier stage, MU researchers say
3. Researchers Test Laxative-Free Colon Scan
4. Mayo Clinic researchers discover biomarkers for prostate cancer detection, recurrence
5. Researchers discover how to overcome poor response to radiotherapy caused by low haemoglobin levels
6. Researchers see BPA effects in monkey mammary glands
7. Geisel researchers sift through junk to find colorectal cancer clues
8. Email vacations decrease stress, increase concentration, researchers say
9. Researchers Rejuvenate Blood-Forming Stem Cells in Mice
10. CNIO researchers describe new functions of cohesin relevant for human disease
11. Biomedical researchers receive Hartwell Foundation awards
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... Modern couples have countless strains ... Counseling’s Sexuality and Relationship Workshops, couples are learning ... healthier habits for their relationship. There are both ... and individuals at Texas Counseling. Their goal is ... skills to develop long term solutions. , ...
(Date:5/21/2013)... Serum Repository (DoDSR), University of Cincinnati (UC) researchers have ... (IBD), which could help with earlier diagnosis and intervention ... This finding, the first of its kind and led ... podium presentation by staff from Walter Reed National Military ... May 18-21 in Orlando, Fla. , The DoDSR ...
(Date:5/21/2013)... 21, 2013 The Las Vegas personal injury ... announce that Crawford Gates, a senior at Coronado High School, ... scholarship essay contest . As the winner of the essay ... contest started on Dec. 1, 2012 and ran through April ... submit a three-page minimum essay on “The Role of the ...
(Date:5/21/2013)... Durham, NC (PRWEB) May 21, 2013 ... STEM CELLS Translational Medicine indicates that stem cells harvested ... from bone marrow in helping to modulate the body’s ... implications in developing new stem-cell-based therapies, as adipose tissue-derived ... body than those found in bone marrow and can ...
(Date:5/21/2013)... (PRWEB) May 22, 2013 About one ... the Fertility Clinics industry one of the ... assists patients who are unable to conceive naturally through ... popular of which is in-vitro fertilisation (IVF) cycles. Over ... cycles in Australia has increased by 4.4% per annum ...
Breaking Medicine News(10 mins):Health News:Workshops Offered To Identify Underlying Challenges That Put Strain On Relationships 2Health News:Biomarkers discovered for inflammatory bowel disease 2Health News:Benson, Bertoldo, Baker & Carter is Pleased to Announce the Winner of its First Annual College Scholarship Essay Contest 2Health News:Stem Cells from Fat Outperform Those from Bone Marrow in Fighting Disease 2Health News:Stem Cells from Fat Outperform Those from Bone Marrow in Fighting Disease 3Health News:Fertility Clinics in Australia Industry Market Research Report Now Available from IBISWorld 2Health News:Fertility Clinics in Australia Industry Market Research Report Now Available from IBISWorld 3
... SHENZHEN, China, Aug. 10 /PRNewswire-Asia-FirstCall/ -- Mindray Medical,International Limited (NYSE: ... devices worldwide announced today its selected unaudited,financial results for the second ... Highlights for Second Quarter and First Half 2009, ... an increase of, 9.9% over ...
... , , FRAMINGHAM, Mass. ... HTWR ) (ASX: HIN) today announced that it has entered into ... United States to sell approximately 2.5 million shares of its common ... have agreed to purchase the shares at a purchase price of ...
... Study found women with familial history of disease were protected ... their babies even for short periods of time may lower ... a family history of the disease. , "We saw ... with a family history who had ever breast-fed," stated Dr. ...
... , , WASHINGTON, Aug. ... health insurance is an immigrant (legal or illegal) or the U.S.-born ... account for one-fourth of those on Medicaid. While there has ... proposed government insurance plans, the enormous impact of immigration, both legal ...
... Search for Family of the Year -- Winning Family Receives Trip to ... , , GREENWICH, Conn., Aug. 10 Think your family ... part of its Pure Life / B e st ... Ne s tle(R) Pure Life(R) bottled water , ...
... , PALO ALTO, Calif., Aug. 10 ... will report its second quarter 2009 financial results on Tuesday, August 11, ... to discuss the results, provide guidance for 2009, and give a company ... Time. , , The live webcast and press release ...
Cached Medicine News:Health News:Mindray Announces Second Quarter 2009 Financial Results 2Health News:Mindray Announces Second Quarter 2009 Financial Results 3Health News:Mindray Announces Second Quarter 2009 Financial Results 4Health News:Mindray Announces Second Quarter 2009 Financial Results 5Health News:Mindray Announces Second Quarter 2009 Financial Results 6Health News:Mindray Announces Second Quarter 2009 Financial Results 7Health News:Mindray Announces Second Quarter 2009 Financial Results 8Health News:Mindray Announces Second Quarter 2009 Financial Results 9Health News:Mindray Announces Second Quarter 2009 Financial Results 10Health News:Mindray Announces Second Quarter 2009 Financial Results 11Health News:Mindray Announces Second Quarter 2009 Financial Results 12Health News:Mindray Announces Second Quarter 2009 Financial Results 13Health News:Mindray Announces Second Quarter 2009 Financial Results 14Health News:Mindray Announces Second Quarter 2009 Financial Results 15Health News:Mindray Announces Second Quarter 2009 Financial Results 16Health News:Mindray Announces Second Quarter 2009 Financial Results 17Health News:Mindray Announces Second Quarter 2009 Financial Results 18Health News:HeartWare International, Inc. Announces US$55 Million Financing 2Health News:HeartWare International, Inc. Announces US$55 Million Financing 3Health News:Breast-Feeding May Lower Breast Cancer Risk 2Health News:Breast-Feeding May Lower Breast Cancer Risk 3Health News:Could Your Family Be The 'Family of the Year?' 2Health News:Could Your Family Be The 'Family of the Year?' 3Health News:Could Your Family Be The 'Family of the Year?' 4Health News:Could Your Family Be The 'Family of the Year?' 5
(Date:5/21/2013)... 2013  Tom Daulton, CEO of Mammotome, a division of ... by the Cincinnati chapter of the ... another local top executive who is also a breast cancer ... Endo-Surgery in March of 2010. Daulton will be presented with ... by Huntington Bank, on May 22. The ACG ...
(Date:5/21/2013)... 2013  LCA-Vision Inc. (NASDAQ: LCAV ), a ... Plus ® brand, announces that all nominees to the company,s ... annual meeting of stockholders.  These Directors are: , ... Bahl & Gaynor Investment Counsel , John ... Edgar F. Heizer III , Chairman of ...
(Date:5/21/2013)... Kepner-Tregoe (KT), the global capability development ... Chris Geraghty has been ... than 20 years serving the industrial sector, holding ... succeeds Ray Baxter , who ... the Board and CEO. (Logo: ...
Breaking Medicine Technology:Tom Daulton, Mammotome CEO, Named ACG Dealmaker of the Year 2Tom Daulton, Mammotome CEO, Named ACG Dealmaker of the Year 3LCA-Vision Reports on Annual Meeting of Stockholders 2LCA-Vision Reports on Annual Meeting of Stockholders 3LCA-Vision Reports on Annual Meeting of Stockholders 4Kepner-Tregoe, Inc. Promotes Chris Geraghty to Chief Executive Officer 2Kepner-Tregoe, Inc. Promotes Chris Geraghty to Chief Executive Officer 3
... 2011 Reportlinker.com announces that a ... in its catalogue: ... – Bone Grafting and Hyaluronic Acid ... http://www.reportlinker.com/p0488653/European-Markets-for-Orthopedic-Biomaterials-2011-–-Bone-Grafting-and-Hyaluronic-Acid-Viscosupplementation-15-Countries.html The ...
... (Nasdaq: STXS ) continued leadership in the ... will again be prominently detailed in the scientific program ... San Francisco, California. Ten podium presentations and ten posters ... of magnetic navigation in the treatment of a variety ...
Cached Medicine Technology:Reportlinker Adds European Markets for Orthopedic Biomaterials 2011 - Bone Grafting and Hyaluronic Acid Viscosupplementation (15 Countries) 2Reportlinker Adds European Markets for Orthopedic Biomaterials 2011 - Bone Grafting and Hyaluronic Acid Viscosupplementation (15 Countries) 3Reportlinker Adds European Markets for Orthopedic Biomaterials 2011 - Bone Grafting and Hyaluronic Acid Viscosupplementation (15 Countries) 4Reportlinker Adds European Markets for Orthopedic Biomaterials 2011 - Bone Grafting and Hyaluronic Acid Viscosupplementation (15 Countries) 5Reportlinker Adds European Markets for Orthopedic Biomaterials 2011 - Bone Grafting and Hyaluronic Acid Viscosupplementation (15 Countries) 6Reportlinker Adds European Markets for Orthopedic Biomaterials 2011 - Bone Grafting and Hyaluronic Acid Viscosupplementation (15 Countries) 7Reportlinker Adds European Markets for Orthopedic Biomaterials 2011 - Bone Grafting and Hyaluronic Acid Viscosupplementation (15 Countries) 8Reportlinker Adds European Markets for Orthopedic Biomaterials 2011 - Bone Grafting and Hyaluronic Acid Viscosupplementation (15 Countries) 9Reportlinker Adds European Markets for Orthopedic Biomaterials 2011 - Bone Grafting and Hyaluronic Acid Viscosupplementation (15 Countries) 10Reportlinker Adds European Markets for Orthopedic Biomaterials 2011 - Bone Grafting and Hyaluronic Acid Viscosupplementation (15 Countries) 11Reportlinker Adds European Markets for Orthopedic Biomaterials 2011 - Bone Grafting and Hyaluronic Acid Viscosupplementation (15 Countries) 12Reportlinker Adds European Markets for Orthopedic Biomaterials 2011 - Bone Grafting and Hyaluronic Acid Viscosupplementation (15 Countries) 13Reportlinker Adds European Markets for Orthopedic Biomaterials 2011 - Bone Grafting and Hyaluronic Acid Viscosupplementation (15 Countries) 14Reportlinker Adds European Markets for Orthopedic Biomaterials 2011 - Bone Grafting and Hyaluronic Acid Viscosupplementation (15 Countries) 15Reportlinker Adds European Markets for Orthopedic Biomaterials 2011 - Bone Grafting and Hyaluronic Acid Viscosupplementation (15 Countries) 16Reportlinker Adds European Markets for Orthopedic Biomaterials 2011 - Bone Grafting and Hyaluronic Acid Viscosupplementation (15 Countries) 17Reportlinker Adds European Markets for Orthopedic Biomaterials 2011 - Bone Grafting and Hyaluronic Acid Viscosupplementation (15 Countries) 18Stereotaxis' Continued Leadership in Scientific Outcome Data Prominently Displayed with Multiple Key Presentations at HRS 2011 2Stereotaxis' Continued Leadership in Scientific Outcome Data Prominently Displayed with Multiple Key Presentations at HRS 2011 3Stereotaxis' Continued Leadership in Scientific Outcome Data Prominently Displayed with Multiple Key Presentations at HRS 2011 4Stereotaxis' Continued Leadership in Scientific Outcome Data Prominently Displayed with Multiple Key Presentations at HRS 2011 5
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: